Literature DB >> 32251033

Naloxone perspectives from people who use opioids: Findings from an ethnographic study in three states.

Miriam Boeri1, Aukje K Lamonica2.   

Abstract

BACKGROUND: Naloxone is an opioid antagonist that can reverse an opioid overdose. Increased opioid-related mortality rates led to greater distribution of naloxone without a prescription and administration of naloxone by laypersons. This study fills a gap in knowledge of naloxone experiences among active users of opioids living in suburban communities.
PURPOSE: The purpose of this article is to provide nurse practitioners with an in-depth understanding of current naloxone use practices among people who experience overdose events. The specific aims are to compare access to naloxone in diverse suburban towns, to examine administration differences across settings, and to understand perspectives on naloxone experiences from people who are actively using opioids. METHODOLOGICAL ORIENTATION: The data for this analysis were drawn from an ethnographic study in the suburban towns around Atlanta, Georgia; Boston, Massachusetts; and New Haven, Connecticut. Short surveys and in-depth interviews were collected. Inductive methods were used to compare data across settings. SAMPLE: The sample of 106 included 48% female, 62% White, 24% African American/Black, 13% more than one race, and 21% Hispanic/Latinx. The mean age was 41.35 years.
CONCLUSIONS: Differences between study settings in access to naloxone, administration frequency, and delivery systems were found. Findings suggest more education and training is needed in overdose prevention and harm reduction intervention. Studies on delivery systems need to address the increase in fentanyl-related overdoses. IMPLICATIONS FOR PRACTICE: Nurse practitioners can help to target distribution of naloxone in local communities, facilitate collaboration with harm reduction services, and provide evidence-based education and training to laypersons.
Copyright © 2020 American Association of Nurse Practitioners.

Entities:  

Year:  2020        PMID: 32251033      PMCID: PMC7529894          DOI: 10.1097/JXX.0000000000000371

Source DB:  PubMed          Journal:  J Am Assoc Nurse Pract        ISSN: 2327-6886            Impact factor:   1.165


  27 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  Research with participants in problem experience: challenges and strategies.

Authors:  Victor N Shaw
Journal:  Qual Health Res       Date:  2005-07

3.  Yes, people can die from opiate withdrawal.

Authors:  Shane Darke; Sarah Larney; Michael Farrell
Journal:  Addiction       Date:  2016-08-11       Impact factor: 6.526

4.  The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths.

Authors:  Ravi Gupta; Nilay D Shah; Joseph S Ross
Journal:  N Engl J Med       Date:  2016-12-08       Impact factor: 91.245

Review 5.  Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review.

Authors:  Shawn A Ryan; Robert B Dunne
Journal:  Pain Manag       Date:  2018-04-23

6.  Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.

Authors:  Michael A Irvine; Jane A Buxton; Michael Otterstatter; Robert Balshaw; Reka Gustafson; Mark Tyndall; Perry Kendall; Thomas Kerr; Mark Gilbert; Daniel Coombs
Journal:  Lancet Public Health       Date:  2018-04-18

7.  Implementing an overdose education and naloxone distribution program in a health system.

Authors:  Jennifer Devries; Sally Rafie; Gregory Polston
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-21

8.  Methamphetamine use among suburban women: implications for nurse practitioners.

Authors:  Annette Bairan; Miriam Boeri; Janice Morian
Journal:  J Am Assoc Nurse Pract       Date:  2014-02-10       Impact factor: 1.165

9.  Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?

Authors:  John Strang; Rebecca McDonald; Basak Tas; Ed Day
Journal:  Addiction       Date:  2016-02-03       Impact factor: 6.526

Review 10.  Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.

Authors:  Todd Kerensky; Alexander Y Walley
Journal:  Addict Sci Clin Pract       Date:  2017-01-07
View more
  4 in total

1.  Green Hope: Perspectives on Cannabis from People who Use Opioids.

Authors:  Miriam Boeri; Elise Pereira; Alina Minkova; Kevin Marcato; Elianne Martinez; Denise Woodall
Journal:  Sociol Inq       Date:  2020-02-13

2.  Circumstances of overdose among suburban women who use opioids: Extending an urban analysis informed by drug, set, and setting.

Authors:  Aukje K Lamonica; Miriam Boeri; Jeffrey Turner
Journal:  Int J Drug Policy       Date:  2020-12-26

Review 3.  Perspectives of Stakeholders of Equitable Access to Community Naloxone Programs: A Literature Review.

Authors:  Lucas Martignetti; Winnie Sun
Journal:  Cureus       Date:  2022-01-20

4.  Barriers and Motivators to Opioid Treatment Among Suburban Women Who Are Pregnant and Mothers in Caregiver Roles.

Authors:  Miriam Boeri; Aukje K Lamonica; Jeffrey M Turner; Amanda Parker; Grace Murphy; Carly Boccone
Journal:  Front Psychol       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.